找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES 2024/2025影响因子:6.627 (CRIT REV CL LAB SCI) (1040-8363). (MEDICAL

[复制链接]
楼主: 不同
发表于 2025-3-23 12:42:01 | 显示全部楼层
Submitted on: 26 November 2006. Revised on: 30 December 2006. Accepted on: 02 February 2007. ___________________CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
发表于 2025-3-23 16:17:48 | 显示全部楼层
Submitted on: 01 January 2017. Revised on: 16 March 2017. Accepted on: 04 May 2017. ___________________CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
发表于 2025-3-23 19:09:56 | 显示全部楼层
Submitted on: 03 April 2009. Revised on: 21 May 2009. Accepted on: 02 July 2009. ___________________CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
发表于 2025-3-24 01:12:45 | 显示全部楼层
Submitted on: 12 September 2008. Revised on: 12 November 2008. Accepted on: 12 December 2008. ___________________CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
发表于 2025-3-24 03:17:16 | 显示全部楼层
Submitted on: 09 September 2018. Revised on: 05 December 2018. Accepted on: 27 January 2019. ___________________CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
发表于 2025-3-24 10:11:19 | 显示全部楼层
发表于 2025-3-24 11:39:47 | 显示全部楼层
Submitted on: 01 February 2021. Revised on: 02 March 2021. Accepted on: 22 April 2021. ___________________CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
发表于 2025-3-24 16:34:58 | 显示全部楼层
Submitted on: 27 September 2012. Revised on: 18 October 2012. Accepted on: 24 November 2012. ___________________CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
发表于 2025-3-24 20:30:02 | 显示全部楼层
Submitted on: 24 January 2008. Revised on: 25 March 2008. Accepted on: 20 May 2008. ___________________CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
发表于 2025-3-24 23:52:27 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-29 23:45
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表